HomeCERS • NASDAQ
Follow
Cerus Corp
Previous close
$1.79
Day range
$1.79 - $1.91
Year range
$1.21 - $3.08
Market cap
341.72M USD
Avg Volume
2.14M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 46.77M | 6.21% |
Operating expense | 24.98M | -27.56% |
Net income | -1.33M | 90.25% |
Net profit margin | -2.84 | 90.82% |
Earnings per share | -0.01 | 87.50% |
EBITDA | 1.62M | 117.45% |
Effective tax rate | -5.47% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 65.85M | -35.54% |
Total assets | 197.75M | -9.33% |
Total liabilities | 144.30M | -3.49% |
Total equity | 53.44M | — |
Shares outstanding | 181.28M | — |
Price to book | 6.17 | — |
Return on assets | 1.21% | — |
Return on capital | 1.66% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -1.33M | 90.25% |
Cash from operations | -15.18M | -764.64% |
Cash from investing | 8.22M | 11.28% |
Cash from financing | 1.18M | 158.86% |
Net change in cash | -5.80M | -189.44% |
Free cash flow | -15.89M | -3,488.51% |
About
Cerus Corporation is an American multinational biotechnology company headquartered in Concord, California that develops and provides a treatment system to pathogen-reduce human blood products for the healthcare industry. Wikipedia
Founded
Sep 1991
Headquarters
Website
Employees
631